Clinical Trial Update: Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12 [Phase 2]

View source ↗

Summary

Phase 2 adjuvant therapy trial in high-risk breast cancer combining weekly doxorubicin and oral cyclophosphamide with G-CSF for 12 weeks and weekly paclitaxel f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Neupogen (Filgrastim)
• Taxol (paclitaxel)

Snippet

Sponsor: University of Washington | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED